|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N\ Engl J Med. 352:987–996. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
McAleavey PG, Walls GM and Chalmers AJ:
Radiotherapy-drug combinations in the treatment of glioblastoma: A
brief review. CNS Oncol. 11(CNS86)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yuen CA, Barbaro M and Haggiagi A: Newly
diagnosed glioblastoma in elderly patients. Curr Oncol Rep.
24:325–334. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wilson MA and Schuchter LM: Chemotherapy
for Melanoma. Cancer Treat Res. 167:209–229. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Harries M, Malvehy J, Lebbe C, Heron L,
Amelio J, Szabo Z and Schadendorf D: Treatment patterns of advanced
malignant melanoma (stage III-IV)-A review of current standards in
Europe. Eur J Cancer. 60:179–189. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Khunger A, Buchwald ZS, Lowe M, Khan MK,
Delman KA and Tarhini AA: Neoadjuvant therapy of locally/regionally
advanced melanoma. Ther Adv Med Oncol.
11(1758835919866959)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pietrantonio F, Randon G, Romagnoli D, Di
Donato S, Benelli M and de Braud F: Biomarker-guided implementation
of the old drug temozolomide as a novel treatment option for
patients with metastatic colorectal cancer. Cancer Treat Rev.
82(101935)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mollazadegan K, Welin S and Crona J:
Systemic treatment of gastroenteropancreatic neuroendocrine
carcinoma. Curr Treat Options Oncol. 22(68)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Scaringi C, De Sanctis V, Minniti G and
Enrici RM: Temozolomide-related hematologic toxicity. Onkologie.
36:444–449. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Le Rhun E, Oppong FB, Vanlancker M, Stupp
R, Nabors B, Chinot O, Wick W, Preusser M, Gorlia T and Weller M:
Prognostic significance of therapy-induced myelosuppression in
newly diagnosed glioblastoma. Neuro Oncol. 24:1533–1545.
2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gilbar PJ, Pokharel K and Mangos HM:
Temozolomide-induced aplastic anaemia: Case report and review of
the literature. J Oncol Pharm Pract. 27:1275–1280. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ahn GS, Hwang K, Kim TM, Park CK, Chang
JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, et al: Influence of
Concurrent and Adjuvant Temozolomide on Health-Related Quality of
Life of Patients with Grade III Gliomas: A Secondary Analysis of a
Randomized Clinical Trial (KNOG-1101 Study). Cancer Res Treat.
54:396–405. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hilverda K, Bosma I, Heimans JJ, Postma
TJ, Peter Vandertop W, Slotman BJ, Buter J, Reijneveld JC and Klein
M: Cognitive functioning in glioblastoma patients during
radiotherapy and temozolomide treatment: Initial findings. J
Neurooncol. 97:89–94. 2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lombardi G, Bergo E, Del Bianco P, Bellu
L, Pambuku A, Caccese M, Trentin L and Zagonel V: Quality of life
perception, cognitive function, and psychological status in a
real-world population of glioblastoma patients treated with
Radio-therapy and Temozolomide: A single-center prospective study.
Am J Clin Oncol. 41:1263–1271. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rooney AG, Brown PD, Reijneveld JC and
Grant R: Depression in glioma: A primer for clinicians and
researchers. J Neurol Neurosurg Psychiatry. 85:230–235.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Q, Qi F, Song X, Di J, Zhang L, Zhou
Y, Lu X, Chang J and Yu Y: A prospective longitudinal evaluation of
cognition and depression in postoperative patients with high-grade
glioma following radiotherapy and chemotherapy. J Cancer Res Ther.
14 (Supplement):S1048–S1051. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pereira-Caixeta AR, Guarnieri LO, Medeiros
DC, Mendes EMAM, Ladeira LCD, Pereira MT, Moraes MFD and Pereira
GS: Inhibiting constitutive neurogenesis compromises long-term
social recognition memory. Neurobiol Learn Mem. 155:92–103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dey D, Parihar VK, Szabo GG, Klein PM,
Tran J, Moayyad J, Ahmed F, Nguyen QA, Murry A, Merriott D, et al:
Neurological impairments in mice subjected to irradiation and
chemotherapy. Radiat Res. 193:407–424. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Egeland M, Guinaudie C, Du Preez A,
Musaelyan K, Zunszain PA, Fernandes C, Pariante CM and Thuret S:
Depletion of adult neurogenesis using the chemotherapy drug
temozolomide in mice induces behavioural and biological changes
relevant to depression. Transl Psychiatry. 7(e1101)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gan H, Zhang Q, Zhu B, Wu S and Chai D:
Fluoxetine reverses brain radiation and temozolomide-induced
anxiety and spatial learning and memory defect in mice. J
Neurophysiol. 121:298–305. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nokia MS, Anderson ML and Shors TJ:
Chemotherapy disrupts learning, neurogenesis and theta activity in
the adult brain. Eur J Neurosci. 36:3521–3530. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pathak N, Cheruku SP, Rao V, Vibhavari
RJA, Sumalatha S, Gourishetti K, Rao CM and Kumar N:
Dehydrozingerone protects temozolomide-induced cognitive impairment
in normal and C6 glioma rats besides enhancing its anticancer
potential. 3 Biotech. 10(438)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Minniti G, Scaringi C, Baldoni A, Lanzetta
G, De Sanctis V, Esposito V and Enrici RM: Health-related quality
of life in elderly patients with newly diagnosed glioblastoma
treated with short-course radiation therapy plus concomitant and
adjuvant temozolomide. Int J Radiat Oncol Biol Phys. 86:285–291.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Minniti G, Lombardi G and Paolini S:
Glioblastoma in elderly patients: Current management and future
perspectives. Cancers (Basel). 11(336)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Suhovskih AV, Molodykh OP, Ushakov VS,
Politko MO, Sokolov DK, Koldysheva EV and Grigorieva EV: Long-Term
exposure to temozolomide affects locomotor activity and cartilage
structure of elderly experimental rats. Biomedicines.
8(541)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Afshari AR, Sanati M, Aminyavari S,
Shakeri F, Bibak B, Keshavarzi Z, Soukhtanloo M, Jalili-Nik M,
Sadeghi MM, Mollazadeh H, et al: Advantages and drawbacks of
dexamethasone in glioblastoma multiforme. Crit Rev Oncol Hematol.
172(103625)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nguyen ET, Streicher J, Berman S, Caldwell
JL, Ghisays V, Estrada CM, Wulsin AC and Solomon MB: A mixed
glucocorticoid/mineralocorticoid receptor modulator dampens
endocrine and hippocampal stress responsivity in male rats.
PhysiolBehav. 178:82–92. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nayana J, Shankaranarayana Rao BS and
Srikumar BN: Mifepristone's effects on depression- and anxiety-like
behavior in rodents. Steroids. 184(109058)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lenze EJ, Hershey T, Newcomer JW, Karp JF,
Blumberger D, Anger J, Doré P and Dixon D: Antiglucocorticoid
therapy for older adults with anxiety and co-occurring cognitive
dysfunction: Results from a pilot study with mifepristone. Int J
Geriatr Psychiatry. 29:962–969. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Mantilla EC Jr, Abramowitz J, Dan TU and
Pan E: Prolonged steroid dependence in adult patients with glioma.
Anticancer Res. 40:2059–2064. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Skupio U, Tertil M, Sikora M, Golda S,
Wawrzczak-Bargiela A and Przewlocki R: Behavioral and molecular
alterations in mice resulting from chronic treatment with
dexamethasone: Relevance to depression. Neuroscience. 286:141–150.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Vafaei AA, Rashidy-Pour A and Taherian AA:
Peripheral injection of dexamethasone modulates anxiety related
behaviors in mice: An interaction with opioidergic neurons. Pak J
Pharm Sci. 21:285–289. 2008.PubMed/NCBI
|
|
33
|
Gómez-Oliva R, Domínguez-García S,
Carrascal L, Abalos-Martínez J, Pardillo-Díaz R, Verástegui C,
Castro C, Nunez-Abades P and Geribaldi-Doldán N: Evolution of
experimental models in the study of glioblastoma: Toward finding
efficient treatments. Front Oncol. 10(614295)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Martin S, Janouskova H and Dontenwill M:
Integrins and p53 pathways in glioblastoma resistance to
temozolomide. Front Oncol. 2(157)2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Dong F, Eibach M, Bartsch JW, Dolga AM,
Schlomann U, Conrad C, Schieber S, Schilling O, Biniossek ML,
Culmsee C, et al: The metalloprotease-disintegrin ADAM8 contributes
to temozolomide chemoresistance and enhanced invasiveness of human
glioblastoma cells. Neuro Oncol. 17:1474–1485. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Farace C, Oliver JA, Melguizo C, Alvarez
P, Bandiera P, Rama AR, Malaguarnera G, Ortiz R, Madeddu R and
Prados J: Microenvironmental modulation of decorin and lumican in
temozolomide-resistant glioblastoma and neuroblastoma cancer
stem-like cells. PLoS One. 10(e0134111)2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sayegh ET, Kaur G, Bloch O and Parsa AT:
Systematic review of protein biomarkers of invasive behavior in
glioblastoma. Mol Neurobiol. 49:1212–1244. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pibuel MA, Poodts D, Díaz M, Hajos SE and
Lompardía SL: The scrambled story between hyaluronan and
glioblastoma. J Biol Chem. 296(100549)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tsidulko AY, Bezier C, de La Bourdonnaye
G, Suhovskih AV, Pankova TM, Kazanskaya GM, Aidagulova SV and
Grigorieva EV: Conventional Anti-glioblastoma chemotherapy affects
proteoglycan composition of brain extracellular matrix in rat
experimental model in vivo. Front Pharmacol. 9(1104)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tsidulko AY, Shevelev OB, Khotskina AS,
Kolpakova MA, Suhovskih AV, Kazanskaya GM, Volkov AM, Aidagulova
SV, Zavyalov EL and Grigorieva EV: Chemotherapy-Induced degradation
of glycosylated components of the brain extracellular matrix
promotes glioblastoma relapse development in an animal model. Front
Oncol. 11(713139)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Walf AA and Frye CA: The use of the
elevated plus maze as an assay of anxiety-related behavior in
rodents. Nat Protoc. 2:322–328. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pádua Carobrez A, Kincheski GC and
Bertoglio LJ: Elevated Plus. Maze. In: Encyclopedia of
Psychopharmacology. Stolerman I.P. (ed). Springer, Berlin,
Heidelberg, 2010.
|
|
43
|
Livak KJ and Schmittgen TD: . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Freireich EJ, Gehan EA, Rall DP, Schmidt
LH and Skipper HE: Quantitative comparison of toxicity of
anticancer agents in mouse, rat, hamster, dog, monkey and man.
Cancer Chemother Rep. 50:219–244. 1966.PubMed/NCBI
|
|
45
|
Reyderman L, Statkevich P, Thonoor CM,
Patrick J, Batra VK and Wirth M: Disposition and pharmacokinetics
of temozolomide in rat. Xenobiotica. 34:487–500. 2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kostaras X, Cusano F, Kline GA, Roa W and
Easaw J: Use of dexamethasone in patients with high-grade glioma: A
clinical practice guideline. Curr Oncol. 21:e493–e503.
2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen X, Lin YP, Wang D and Zhang JN:
Dexamethasone exacerbates spatial acquisition deficits after
traumatic brain injury in rats. Neurol Res. 32:1097–1102.
2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
From the American Association of
Neurological Surgeons (AANS), American Society of Neuroradiology
(ASNR), Cardiovascular and Interventional Radiology Society of
Europe (CIRSE), Canadian Interventional Radiology Association
(CIRA), Congress of Neurological Surgeons (CNS), European Society
of Minimally Invasive Neurological Therapy (ESMINT), European
Society of Neuroradiology (ESNR), European Stroke Organization
(ESO), Society for Cardiovascular Angiography and Interventions
(SCAI), Society of Interventional Radiology (SIR) et al.
Multisociety Consensus Quality Improvement Revised Consensus
Statement for Endovascular Therapy of Acute Ischemic Stroke. Int J
Stroke. 13:612–632. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yao YY, Liu DM, Xu DF and Li WP: Memory
and learning impairment induced by dexamethasone in senescent but
not young mice. Eur J Pharmacol. 574:20–28. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Narang VS, Fraga C, Kumar N, Shen J, Throm
S, Stewart CF and Waters CM: Dexamethasone increases expression and
activity of multidrug resistance transporters at the rat
blood-brain barrier. Am J Physiol Cell Physiol. 295:C440–C450.
2008.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Drakulić D, Veličković N, Stanojlović M,
Grković I, Mitrović N, Lavrnja I and Horvat A: Low-dose
dexamethasone treatment promotes the pro-survival signalling
pathway in the adult rat prefrontal cortex. J Neuroendocrinol.
25:605–616. 2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Drakulić D, Stanojlović M, Nedeljković N,
Grković I, Veličković N, Guševac I, Mitrović N, Buzadžić I and
Horvat A: Upregulation of nucleoside triphosphate
diphosphohydrolase-1 and ecto-5'-nucleotidase in rat hippocampus
after re-peated low-dose dexamethasone administration. J Mol
Neurosci. 55:959–967. 2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Huang B, Yu Z and Liang R: Effect of
long-term adjuvant temozolomide chemotherapy on primary
glioblastoma patient survival. BMC Neurol. 21(424)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rowlands D, Lensjø KK, Dinh T, Yang S,
Andrews MR, Hafting T, Fyhn M, Fawcett JW and Dick G: Aggrecan
directs extracellular matrix-mediated neuronal plasticity. J
Neurosci. 38:10102–10113. 2018.PubMed/NCBI View Article : Google Scholar
|
